differentiation 86 Search Results


rat soluble cluster of differentiation 86, scd86 genlisa elisa  (Krishgen Biosystems)
N/A
ELISA for the quantitative determination rat soluble Cluster of differentiation 86, sCD86 in rat samples.
   Buy from Supplier
human cd86  (Cusabio)
93
Cusabio human cd86
Cox regression analysis for various potential prognostic factors in overall survival in all cases
Human Cd86, supplied by Cusabio, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/differentiation+86/Human+soluble+Cluster+of+differentiation+86%2CsCD86+ELISA+Kit/pmc04971909-102-25-28
Average 93 stars, based on 1 article reviews
human cd86 - by Bioz Stars, 2026-10
93/100 stars
  Buy from Supplier
cd86  (Cusabio)
90
Cusabio cd86
Figure 5. Enzyme-linked immunosorbent assay analysis of different M1/M2 microglia markers and soluble mediators secreted by M1/M2 microglia in the hippocampus. (A and B) BCP induced increase in M1 marker <t>CD86</t> and proinflammatory cytokines TNF-α and IL-1β, while were alleviated by minocycline. (C and D) BCP failed to make any change in M2 marker MRC1 and proinflammatory cytokine IL-10, while minocy- cline upregulated them. There was no difference in IL-4 among the 3 groups. The data are expressed as the mean ± SD (n = 4). **P < .01, ***P < .001, “sham + vehicle” versus “BCP + vehicle” and #P < .05, ##P < .01, “BCP + vehicle” versus “BCP + mino.” BCP indicates bone cancer pain; ELISA, enzyme-linked immunosorbent assay; IL, interleukin; mino, minocycline; TNF, tumor necrosis factor.
Cd86, supplied by Cusabio, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/differentiation+86/Rat+soluble+Cluster+of+differentiation+86%2CsCD86+ELISA+Kit/10__1213_slash_ane__0000000000004063-102-26-29
Average 90 stars, based on 1 article reviews
cd86 - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier
primary antibody 178 against neun  (Servicebio Inc)
86
Servicebio Inc primary antibody 178 against neun
Figure 5. Enzyme-linked immunosorbent assay analysis of different M1/M2 microglia markers and soluble mediators secreted by M1/M2 microglia in the hippocampus. (A and B) BCP induced increase in M1 marker <t>CD86</t> and proinflammatory cytokines TNF-α and IL-1β, while were alleviated by minocycline. (C and D) BCP failed to make any change in M2 marker MRC1 and proinflammatory cytokine IL-10, while minocy- cline upregulated them. There was no difference in IL-4 among the 3 groups. The data are expressed as the mean ± SD (n = 4). **P < .01, ***P < .001, “sham + vehicle” versus “BCP + vehicle” and #P < .05, ##P < .01, “BCP + vehicle” versus “BCP + mino.” BCP indicates bone cancer pain; ELISA, enzyme-linked immunosorbent assay; IL, interleukin; mino, minocycline; TNF, tumor necrosis factor.
Primary Antibody 178 Against Neun, supplied by Servicebio Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/differentiation+86/86+against+antibodies+cd86+cluster+differentiation+gb113111+of+primary/pm41462297-69-9-18
Average 86 stars, based on 1 article reviews
primary antibody 178 against neun - by Bioz Stars, 2026-10
86/100 stars
  Buy from Supplier
differential scanning calorimeter jyh-86  (METTLER TOLEDO)
90
METTLER TOLEDO differential scanning calorimeter jyh-86
Figure 5. Enzyme-linked immunosorbent assay analysis of different M1/M2 microglia markers and soluble mediators secreted by M1/M2 microglia in the hippocampus. (A and B) BCP induced increase in M1 marker <t>CD86</t> and proinflammatory cytokines TNF-α and IL-1β, while were alleviated by minocycline. (C and D) BCP failed to make any change in M2 marker MRC1 and proinflammatory cytokine IL-10, while minocy- cline upregulated them. There was no difference in IL-4 among the 3 groups. The data are expressed as the mean ± SD (n = 4). **P < .01, ***P < .001, “sham + vehicle” versus “BCP + vehicle” and #P < .05, ##P < .01, “BCP + vehicle” versus “BCP + mino.” BCP indicates bone cancer pain; ELISA, enzyme-linked immunosorbent assay; IL, interleukin; mino, minocycline; TNF, tumor necrosis factor.
Differential Scanning Calorimeter Jyh 86, supplied by METTLER TOLEDO, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/differentiation+86/differential+scanning+calorimeter+jyh+86/10__1002_slash_app__48753-70-17-21
Average 90 stars, based on 1 article reviews
differential scanning calorimeter jyh-86 - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier
uncoated rat scd86 (soluble cluster of differentiation 86) elisa kit  (Elabscience Biotechnology)
N/A
   Buy from Supplier
mouse soluble cluster of differentiation 86, scd86 genlisa elisa  (Krishgen Biosystems)
N/A
Enzyme Immunoassay for the Quantitative Determination of Mouse soluble Cluster of differentiation 86, sCD86 in serum, plasma, tissues and other biological samples
   Buy from Supplier
bovine cluster of differentiation 86, cd86 genlisa elisa  (Krishgen Biosystems)
N/A
ELISA for estimation of Bovine Cluster of differentiation 86, CD86 in serum, plasma and other biological fluids
   Buy from Supplier
human soluble cluster of differentiation 86, scd86 genlisa elisa  (Krishgen Biosystems)
N/A
ELISA for estimation of Human Soluble Cluster of Differentiation 86, sCD86 in serum, plasma and other biological fluids
   Buy from Supplier
rat scd86 (soluble cluster of differentiation 86) elisa kit  (Elabscience Biotechnology)
N/A
This ELISA kit uses the Sandwich-ELISA principle. The micro ELISA plate provided in this kit has been pre-coated with an antibody specific to Rat sCD86. Standards or samples are added to the micro ELISA plate
   Buy from Supplier

Image Search Results


Cox regression analysis for various potential prognostic factors in overall survival in all cases

Journal: Cancer Medicine

Article Title: Higher preoperative serum levels of PD ‐L1 and B7‐H4 are associated with invasive and metastatic potential and predictable for poor response to VEGF ‐targeted therapy and unfavorable prognosis of renal cell carcinoma

doi: 10.1002/cam4.754

Figure Lengend Snippet: Cox regression analysis for various potential prognostic factors in overall survival in all cases

Article Snippet: The serum levels of B7 family molecules, CD28, and VEGF were measured by using the following ELISA kits: human CD80 (CSB‐E15768h, Cusabio Biotech, Wuhan, China), human CD86 (CSB‐E08542h, Cusabio Biotech, Wuhan, China), human B7‐H4 (CSB‐E15013h, Cusabio Biotech, Wuhan, China), human PD‐1 (CSB‐E13643h, Cusabio Biotech, Wuhan, China), human PD‐L1 (CSB‐E13644h, Cusabio Biotech, Wuhan, China), human CD28 (CSB‐E09296h, Cusabio Biotech, Wuhan, China), human B7‐H3 (DB7H30, R&D Systems, Minneapolis, MN), human VEGF (DVE00, R&D Systems Minneapolis, MN), and human CTLA‐4 (KA0165, Abnova, Taipe, Taiwan), as described previously .

Techniques:

Cox regression analysis for various potential prognostic factors in recurrence‐free survival in 108 N0M0 cases at radical nephrectomy

Journal: Cancer Medicine

Article Title: Higher preoperative serum levels of PD ‐L1 and B7‐H4 are associated with invasive and metastatic potential and predictable for poor response to VEGF ‐targeted therapy and unfavorable prognosis of renal cell carcinoma

doi: 10.1002/cam4.754

Figure Lengend Snippet: Cox regression analysis for various potential prognostic factors in recurrence‐free survival in 108 N0M0 cases at radical nephrectomy

Article Snippet: The serum levels of B7 family molecules, CD28, and VEGF were measured by using the following ELISA kits: human CD80 (CSB‐E15768h, Cusabio Biotech, Wuhan, China), human CD86 (CSB‐E08542h, Cusabio Biotech, Wuhan, China), human B7‐H4 (CSB‐E15013h, Cusabio Biotech, Wuhan, China), human PD‐1 (CSB‐E13643h, Cusabio Biotech, Wuhan, China), human PD‐L1 (CSB‐E13644h, Cusabio Biotech, Wuhan, China), human CD28 (CSB‐E09296h, Cusabio Biotech, Wuhan, China), human B7‐H3 (DB7H30, R&D Systems, Minneapolis, MN), human VEGF (DVE00, R&D Systems Minneapolis, MN), and human CTLA‐4 (KA0165, Abnova, Taipe, Taiwan), as described previously .

Techniques:

Figure 5. Enzyme-linked immunosorbent assay analysis of different M1/M2 microglia markers and soluble mediators secreted by M1/M2 microglia in the hippocampus. (A and B) BCP induced increase in M1 marker CD86 and proinflammatory cytokines TNF-α and IL-1β, while were alleviated by minocycline. (C and D) BCP failed to make any change in M2 marker MRC1 and proinflammatory cytokine IL-10, while minocy- cline upregulated them. There was no difference in IL-4 among the 3 groups. The data are expressed as the mean ± SD (n = 4). **P < .01, ***P < .001, “sham + vehicle” versus “BCP + vehicle” and #P < .05, ##P < .01, “BCP + vehicle” versus “BCP + mino.” BCP indicates bone cancer pain; ELISA, enzyme-linked immunosorbent assay; IL, interleukin; mino, minocycline; TNF, tumor necrosis factor.

Journal: Anesthesia & Analgesia

Article Title: Minocycline Relieves Depressive-Like Behaviors in Rats With Bone Cancer Pain by Inhibiting Microglia Activation in Hippocampus

doi: 10.1213/ane.0000000000004063

Figure Lengend Snippet: Figure 5. Enzyme-linked immunosorbent assay analysis of different M1/M2 microglia markers and soluble mediators secreted by M1/M2 microglia in the hippocampus. (A and B) BCP induced increase in M1 marker CD86 and proinflammatory cytokines TNF-α and IL-1β, while were alleviated by minocycline. (C and D) BCP failed to make any change in M2 marker MRC1 and proinflammatory cytokine IL-10, while minocy- cline upregulated them. There was no difference in IL-4 among the 3 groups. The data are expressed as the mean ± SD (n = 4). **P < .01, ***P < .001, “sham + vehicle” versus “BCP + vehicle” and #P < .05, ##P < .01, “BCP + vehicle” versus “BCP + mino.” BCP indicates bone cancer pain; ELISA, enzyme-linked immunosorbent assay; IL, interleukin; mino, minocycline; TNF, tumor necrosis factor.

Article Snippet: The following microglia marker and secreted factors were measured according to the manufacturer-recommended protocol and quantified with the Multiskan Specturm (Thermo Fisher Scientific, Grand Island, NY): CD86 (Cat# CSBE08543r; Cusabio Biotech, Wuhan, China), tumor necrosis factor-α, interleukin-1β, interleukin-10, interleukin-4 (Cat# RTA00, RLB00, R1000, R4000; R&D Systems, Minneapolis, MN), and MRC1 (Cat# SEB542Ra; Cloud-Clone Corp, Houston, TX).

Techniques: Enzyme-linked Immunosorbent Assay, Marker